Results 21 to 30 of about 67,223 (202)

Does illicit amphetamine seizures quantity associated with amphetamine use disorder related admissions in Saudi Arabia?

open access: yesBMC Psychiatry, 2023
Background Illicit amphetamine-type stimulants (ATS) trafficking activities have increased substantially in Saudi Arabia over the last 10 years. In the period 2013–2017 Saudi Arabia seized the largest quantities of amphetamine at the global level.
Majed Ramadan   +2 more
doaj   +1 more source

Nicotine and Amphetamine Decrease Sucrose Self-Administration

open access: yes, 2023
Limited research exists on how amphetamine and nicotine, drugs with potent influences on feeding behaviors, impact the rewarding and pleasurable aspects of feeding.
Fulco, Cameron
core   +1 more source

Amphetamine-related care in the USA, 2003–2014: cross-sectional analyses examining inpatient trends and factors associated with hospitalisation outcomes

open access: yesBMJ Open, 2022
Objectives Although amphetamine use is a growing health problem in the USA, there are limited data on amphetamine-related hospitalisations. The primary objective of our study was to examine trends in amphetamine-related hospitalisations in the USA ...
Jacquelyn J Cragg   +6 more
doaj   +1 more source

Chemo-Profiling of Illicit Amphetamine Tablets Seized from Jazan, Saudi Arabia, Using Gas Chromatography-Mass Spectrometry and Chemometric Techniques

open access: yesJournal of Chemistry, 2021
A number of illegal drug tablets with unknown constituents are supplied to countries around the world, most of which are habit forming. Amphetamine constitutes the majority of illegal tablets supplied to Saudi Arabia.
Hassan A. Alhazmi   +10 more
doaj   +1 more source

Effects of Food on the Bioavailability of Amphetamine in Healthy Adults After Administration of SHP465 Mixed Amphetamine Salts Extended-Release Capsules

open access: yesDrugs in R&D, 2019
Background and objective SHP465 mixed amphetamine salts extended release is a once-daily, single-entity, mixed amphetamine salts capsule product for attention-deficit/hyperactivity disorder.
Yi Wang   +4 more
doaj   +1 more source

Pharmacology of amphetamine-type designer drugs [PDF]

open access: yes, 2013
In this thesis project, we studied the pharmacology of long-known psychostimulants and of novel amphetamine-type designer drugs in vitro. On the basis of the pharmacological characterization, we focused on the drug effects in humans, investigating the ...
Simmler, Linda
core   +1 more source

Amphetamine elicits opposing actions on readily releasable and reserve pools for dopamine. [PDF]

open access: yesPLoS ONE, 2013
Amphetamine, a highly addictive drug with therapeutic efficacy, exerts paradoxical effects on the fundamental communication modes employed by dopamine neurons in modulating behavior.
Dan P Covey   +2 more
doaj   +1 more source

Pharmacokinetics and Pharmacodynamics of Lisdexamfetamine Compared with D-Amphetamine in Healthy Subjects

open access: yesFrontiers in Pharmacology, 2017
Rationale: Lisdexamfetamine is a prodrug of D-amphetamine used for the treatment of attention-deficit/hyperactivity disorder (ADHD). Lisdexamfetamine is thought to have a prolonged pharmacokinetic profile compared with oral D-amphetamine, possibly ...
Patrick C. Dolder   +5 more
doaj   +1 more source

The effects of caffeine and d-amphetamine on spatial span task in healthy participants.

open access: yesPLoS ONE, 2023
Studies that examined the effect of amphetamine or caffeine on spatial working memory (SWM) and verbal working memory (VWM) have used various tasks.
Faiz M Kassim   +9 more
doaj   +1 more source

Amphetamine-induced alteration to gaze parameters: A novel conceptual pathway and implications for naturalistic behavior

open access: yes, 2021
Amphetamine produces a multiplicity of well-documented end-order biochemical, pharmacological and biobehavioural effects. Mechanistically, amphetamine downregulates presynaptic and postsynaptic striatal monoamine (primarily dopaminergic) systems ...
Amie Hayley (18926854)   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy